MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-13-0008310
Raxxon Pharma Private Limited
Raxxon Pharma Private Limited - pharma in Panchkula, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.03 Cr
▼ 18% YoY
Net loss · FY 2025
₹10.83 Lakh
Net margin -10.5%
EBITDA · FY 2025
₹10.92 Lakh
EBITDA margin 10.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1.7 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Raxxon Pharma Private Limited
Data last updated:
Raxxon Pharma Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U51909HR2021PTC096157. Its GSTIN is 02AALCR1150N1ZE (Himachal Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anurag Mittal and Mohit Mittal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No 164 Sector 11 Panchkula, Haryana, India – 134113.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.03 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net loss of ₹10.83 Lakh (net margin -10.5%) and EBITDA of ₹10.92 Lakh (EBITDA margin 10.6%).
As per MCA filings, the company has open charges of ₹1.7 Cr on record.
Raxxon Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-13-0008310).
Company details
CIN U51909HR2021PTC096157
Registration Number 096157
Incorporation Date 07 July 2021
ROC Haryana
Listing Status Unlisted
Company Status Active
MSME Classification Small
Udyam Registration UDYAM-HR-13-0008310
Key People
Anurag Mittal Director Mohit Mittal Director Recognitions & Rankings of Raxxon Pharma
Contact details
Raxxon Pharma Private Limited's registered office is in Panchkula, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No 164 Sector 11 Panchkula, Haryana, India – 134113
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Raxxon Pharma Private Limited, buy the company report.
Comprehensive company report
Raxxon Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Raxxon Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Raxxon Pharma Private Limited, buy the company report.
Financials of Raxxon Pharma Private Limited
FY 2025 filings availableRaxxon Pharma Private Limited reported revenue of ₹1.03 Cr (down 18% YoY) for FY 2025.
Revenue · FY 2025
₹1.03 Cr ▼ 18%
Net loss · FY 2025
₹10.83 Lakh margin -10.5%
EBITDA · FY 2025
₹10.92 Lakh margin 10.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 18%
EBITDA CAGR growth
1 year
▲ 106%
3 years · compounded
▲ 331%
Revenue fell 18% in the latest year. EBITDA rose 106% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹10.92 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹10.83 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 10.6% | |||
| Net Profit Margin | -10.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Raxxon Pharma Private Limited, buy the company report.
Board of directors of Raxxon Pharma Private Limited
Raxxon Pharma has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anurag Mittal | Director | 07 Jul 2021 | 5 Years 4 Months | Current |
| Mohit Mittal | Director | 07 Jul 2021 | 5 Years 4 Months | Current |
Auditor
Raxxon Pharma Private Limited is audited by THAKRAL PALVI AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| THAKRAL PALVI AND ASSOCIATES | FY 2023 | 026049N |
Shareholding
The shareholding of Raxxon Pharma Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Raxxon Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.7 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Dec 2022 | 100659604 | Others | ₹1.7 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Raxxon Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Raxxon Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Raxxon Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AALCR1150N1ZE | Himachal Pradesh | Active | 18 Oct 2022 |
To see the full GST registrations and return filing status of Raxxon Pharma Private Limited, buy the company report.
Recent activity
Raxxon Pharma Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Anurag Mittal was appointed as Director on 07 Jul 2021.
AGM
Raxxon Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Raxxon Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Charges
A charge with Others amounted to Rs. 170.00 Lakh with Charge ID 100659604 was registered on 16 Dec 2022.
Appointed
Anurag Mittal was appointed as Director.
Appointed
Mohit Mittal was appointed as Director.
Incorporation
07 Jul 2021
Raxxon Pharma Private Limited was registered on 07 Jul 2021 with Roc Haryana & aged 5 years 4 months as per MCA records.
Frequently asked questions
Raxxon Pharma is an active private limited company based in Panchkula, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 July 2021 (5+ years old) and is registered under CIN U51909HR2021PTC096157.
Raxxon Pharma has 2 current directors:
- Anurag Mittal - Director
- Mohit Mittal - Director
The latest financial statements of Raxxon Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Raxxon Pharma is 02AALCR1150N1ZE, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Raxxon Pharma is U51909HR2021PTC096157. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Raxxon Pharma was incorporated on 07 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Haryana.
Anurag Mittal was appointed as Director on 07 Jul 2021. Mohit Mittal was appointed as Director on 07 Jul 2021.
Yes, Raxxon Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-HR-13-0008310).
The registered office of Raxxon Pharma is at House No 164 Sector 11 Panchkula, Haryana, India – 134113.
Raxxon Pharma operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages